CARSON HOMER: Open Payments
NPI 1306462304 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 13 payments from 5 companies in 2025. Trend: 2023 $330 · 2024 $361 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $148 |
| Dexcom, Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: QULIPTA, VRAYLAR, LILETTA, Dexcom G6 Transmitter, INGREZZA, GARDASIL 9, AIRSUPRA, UBRELVY.
Industry payments across UT — which companies pay providers there.
